Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-25T08:34:58.225Z Has data issue: false hasContentIssue false

13 - Abnormal blood concentrations of eosinophils and neutrophils

from Section IV - Leukocyte disorders

Published online by Cambridge University Press:  05 February 2013

Pedro de Alarcón
Affiliation:
University of Illinois College of Medicine
Eric Werner
Affiliation:
Children's Hospital of the King's Daughters
Robert D. Christensen
Affiliation:
McKay-Dee Hospital, Utah
Get access

Summary

Eosinophilia and eosinopenia

Eosinophilia in neonates is identified when the blood concentration of eosinophils exceeds the upper reference range limit. To avoid the potential pitfall of laboratory or technician error, perhaps the definition should be two subsequent eosinophil counts above the upper reference limit. As shown in Fig. 22.17, the 95th percentile for blood concentration of eosinophils increases slightly over the first month following birth. Initially, a count ≥1200/µL would exceed the upper range, and by about 4 weeks a count of above 1500/µL would exceed the upper limit (1). This latter value is similar to that generally used to define eosinophilia in adults (2). Adults with persistent eosinophilia are well advised to have the situation evaluated, because an association has been seen between persistent eosinophilia and end-organ damage (2). Some adults with persistent eosinophilia have elevated blood lnterleulin-5 (IL-5) concentrations (3). Some with hypereosinophilic syndrome have an eosinophilic leukemia involving a translocation in the tyrosine kinase gene (4).

Interleukin-5 (IL-5) probably plays a role as a regulator of eosinophil production. Evidence for this includes the reports of Lee and associates (5) and Dent and coworkers (6) who produced transgenic mice that constitutively over-expressed IL-5. These animals had profound eosinophilia, generally equaling 60% of circulating leukocytes. However, mice with a targeted gene disruption of IL-5 that consequently produce no IL-5, have a reduced number of blood and marrow eosinophils but no other apparent hematologic defects (6). Further evidence that IL-5 regulates eosinophil production comes from studies of Rennick and colleagues (7) and Sher and associates (8) who used specific neutralizing antibody directed against IL-5 and observed that such inhibits the eosinophilia otherwise seen in parasitized mice. More evidence that IL-5 stimulates eosinophil production comes from the work of Lu and colleagues (9) who determined that recombinant murine IL-5 had the greatest effect of any factor tested on colony generation of eosinophilic progenitors.

Type
Chapter
Information
Neonatal Hematology
Pathogenesis, Diagnosis, and Management of Hematologic Problems
, pp. 209 - 230
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Christensen, RD, Jensen, J, Maheshwari, A, Henry, E. Reference ranges for blood concentrations of eosinophils and monocytes during the neonatal period, defined using data from over 80,000 records in a multihospital healthcare system. J Perinatology 2010;30:540–5.CrossRefGoogle Scholar
McCurley, TL, Greer, JP. Diagnostic approach to malignant and nonmalignant disorders of the phagocytic and immune systems. In Wintrobe’s Clinical Hematology. eds, Greer, JP, Foerster, J, Rodgers, GM, Paraskevas, F, Glader, B, Arber, DA, Means, RT, Jr. Philadelphia:Lippincott/Williams & Wilkins, 2009;1513–14.Google Scholar
Simon, H-U, Plotz, SG, Dummer, R, et al. Abnormal clones of T cells producting interleukin-5 in idiopathic eosinophilia. N Eng J Med 1999;341:1112–20.CrossRefGoogle Scholar
Gotlib, J.Molecular classification and pathogenesis of eosinophilic disorders: 2005 update. Acta Haematol 2005;114:7–25.CrossRefGoogle ScholarPubMed
Lee, NA, McGarry, MP, Larson, KA, et al. Expression of IL-5 in the thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol 1997;158:1332–44.Google Scholar
Dent, LA, Strath, M, Mellor, AL, Sanderson, CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:1425–31.CrossRefGoogle ScholarPubMed
Rennick, DM, Thompson-Snipes, L, Coffinan, RL, et al. In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow of parasitized mice. Blood 1990;76:312–16.Google ScholarPubMed
Sher, A, Coffman, RL, Hieny, S, et al. Interleukin-5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Nad Acad Sci USA 1990;87:61–5.CrossRefGoogle Scholar
Lu, L, Lin, ZN, Shen, RN, et al. Influence of interleukins 3, 5, and 6 on the growth of eosinophil progenitors in highly enriched human bone marrow in the absence of serum. Exp Hematol 1990;18:1180–6.Google ScholarPubMed
Brugnoni, D, Airo, R, Rossi, G, et al. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 1996;87:1416–22.Google ScholarPubMed
Okayama, H, Fushimi, T, Sllimura, S, et al. Glucocorticoids suppress production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects. J Allergy Clin ImmunoI 1994;93:1006–12.CrossRefGoogle Scholar
Krishnaswamy, G, Smith, JK, Srikandl, S, et al. Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines. J Interferon Cytokine Res 1996;16:819–27.CrossRefGoogle ScholarPubMed
Walsh, GM, Hartnell, A, Wardlaw, AJ. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner. Immunology 1994;71:258–65.Google Scholar
Medoff, HS, Barbero, GJ. Total blood eosinophil counts in the newborn period. Pediatrics 1950;6:737–42.Google ScholarPubMed
Xanthou, M. Leucocyte blood picture in ill newborn babies. Arch Dis Child 1972;47:741–6.CrossRefGoogle ScholarPubMed
Burrell, JM. A comparative study of the circulating eosinophil levels in babies. Arch Dis Child 1952;27:337–42.CrossRefGoogle Scholar
Bass, DA. Behavior of eosinophil leukocytes in acute inflammation. II Eosinophil dynamics during acute inflammation. J Clin Invest 1975;56:870–9.CrossRefGoogle ScholarPubMed
Gibson, JG Jr, Vaucher, Y, Corrigan, JJ. Eosinophilia in premature infants: relationship to weight gain. J Pediatr 1979;95:99–101.CrossRefGoogle ScholarPubMed
Portuguez-Molavasi, A, Cote-Boileau, T, Aranda, JV. Eosinophilia in the newborn, possible role in adverse drug reactions. Pediatr Res 1980;14:537–8.Google Scholar
Craver, RD. The cytology of cerebrospinal fluid associates with neonatal intraventricular hemorrhage. Pediatr Pathol Lab Med 1996;16:713–19.CrossRefGoogle Scholar
Patel, L, Garvey, B, Arnon, S, Roberts, IA. Eosinophilia in newborn infants. Acta Paediatr 1994;83:797–801.CrossRefGoogle ScholarPubMed
Odelram, H, Bjorksten, B, Leander, E, Kjellman, NI. Predictors of atopy in newborn babies. Allergy 1995;50:585–92.CrossRefGoogle ScholarPubMed
Yamamoto, C, Kojima, T, Hatrori, K, et al. Eosinophilia in premature infants: correlation with chronic lung disease. Acta Paediatr 1996;85:1232–5.CrossRefGoogle ScholarPubMed
Morgan, AJ, Steen, CJ, Schwartz, RA, Janniger, CK. Erythema toxicum neonatorum revisited. Cutis 2009;83:13–16.Google ScholarPubMed
Matsumoto, K, Shimanouchi, Y, Kawakubo, K, et al. Infantile eczema at one month of age is associated with cord blood eosinophilia and subsequent development of atopic dermatitis and wheezing illness until two years of age. Int Arch Allergy Immunol 2005;137:69–76.CrossRefGoogle Scholar
Marchini, G, Ulfgren, AK, Loré, K, Ståbi, B, Berggren, V, Lonne-Rahm, S. Erythema toxicum neonatorum: an immunohistochemical analysis. Pediatr Dermatol. 2001;18:177–87.CrossRefGoogle ScholarPubMed
Ladrigan, MK, LeBoit, PE, Frieden, IJ. Neonatal eosinophilic pustulosis in a 2-month old. Pediatr Dermatol 2008;25:52–5.CrossRefGoogle Scholar
Asgari, M, Leiferman, KM, Piepkorn, M, Kuechle, MK. Neonatal eosinophilic pustulosis. Int J Dermatol 2006;45:131–4.CrossRefGoogle ScholarPubMed
Chiang, YC, Shyur, SD, Huang, LH, et al. Chlamydia trachomatis pneumonia: experience in a medical center. Acta Paediatr Taiwan 2005;46:284–8.Google ScholarPubMed
Lindemans, CA, Kimpen, JL, Luijk, B, Heidema, J, Kanters, D, van der Ent, CK, Koenderman, L. Systemic eosinophil response induced by respiratory syncytial virus. Exp Immunol 2006;144:409–17.CrossRefGoogle ScholarPubMed
Broström, EB, Katz-Salamon, M, Lundahl, J, Halldén, G, Winbladh, B.Eosinophil activation in preterm infants with lung disease. Acta Paediatr 2007;96:23–8.CrossRefGoogle ScholarPubMed
Pentiuk, SP, Miller, CK, Kaul, A.Eosinophilic esophagitis in infants and toddlers. Dysphagia 2007;22:44–8.CrossRefGoogle ScholarPubMed
Ohtsuka, Y, Shimizu, T, Shoji, H, et al. Neonatal transient eosinophilic colitis causes lower gastrointestinal bleeding in early infancy. J Pediatr Gastroenterol Nutr 2007;44:501–5.CrossRefGoogle ScholarPubMed
Tajirian, A, Ross, R, Zeikus, P, Robinson-Bostom, L.Subcutaneous fat necrosis of the newborn with eosinophilic granules. J Cutan Pathol 2007;34:588–90.CrossRefGoogle ScholarPubMed
Juul, SE, Haynes, JW, McPherson, RJ. Evaluation of eosinophilia in hospitalized preterm infants. J Perinatol 2005;25:182–8.CrossRefGoogle ScholarPubMed
Carballo, C, Foucar, K, Swanson, P, Papile, LA, Watterberg, KL. Effect of high altitude on neutrophil counts in newborn infants. J Pediatr 1991;119:464–6.CrossRefGoogle ScholarPubMed
Maynard, EC, Reed, C, Kircher, T. Neutrophil counts in newborn infants at high altitude. J Pediatr 1993;122:990–1.CrossRefGoogle ScholarPubMed
Schmutz, N, Henry, E, Jopling, J, Christensen, RD. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol 2008;28:275–81.CrossRefGoogle ScholarPubMed
Manroe, BL, Weinberg, AG, Rosenfeld, CR, Browne, R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979;95:89–98.CrossRefGoogle ScholarPubMed
Mouzinho, A, Rosenfeld, CR, Sanchez, PJ, Risser, R. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatr 1994;94:76–82.Google ScholarPubMed
Manroe, BL. Neutrophil values in infants born at high altitude. J Pediatr 1992;120:464–6.CrossRefGoogle Scholar
Xanthou, M. Leukocyte blood picture in healthy full term and premature babies during the neonatal period. Arch Dis Child 1970;45:242.CrossRefGoogle ScholarPubMed
Xanthou, M. Leucocyte blood picture in ill newborn babies. Arch Dis Child 1972;47:741.CrossRefGoogle ScholarPubMed
Drossou-Agakidou, V, Kanakoudi-Tsakalidou, F, Sarafidis, K, et al. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial. Eur J Pediatr 1998;157:583–8.CrossRefGoogle Scholar
Rastogi, S, Rastogi, D, Sundaram, R, Kulpa, J, Parekh, AJ. Leukemoid reaction in extremely low-birth-weight infants. Am J Perinatol 1999;16:93–7.CrossRefGoogle ScholarPubMed
Krumbhaar, EB. Leukemoid blood pictures in various clinical conditions. Am J Med Sci 1926;172:519–33.CrossRefGoogle Scholar
Calhoun, DA, Kirk, JF, Christensen, RD. Incidence, significance, and kinetic mechanism responsible for leukemoid reactions in patients in the neonatal intensive care unit: a prospective evaluation. J Pediatr 1996;129:403–9.CrossRefGoogle ScholarPubMed
Zanardo, V, Savio, V, Giacomin, C, Rinaldi, A, Marzari, F, Chiarelli, S. Relationship between neonatal leukemoid reaction and bronchopulmonary dysplasia in low-birth-weight infants: a cross-sectional study. Am J Perinatol 2002;19:379–86.CrossRefGoogle ScholarPubMed
Hsiao, R, Omar, SA. Outcome of extremely low birth weight infants with leukemoid reaction. Pediatrics 2005;116:e43–51.CrossRefGoogle ScholarPubMed
Zanardo, V, Vedovato, S, Trevisanuto, DD, et al. Histological chorioamnionitis and neonatal leukemoid reaction in low-birth-weight infants. Hum Pathol 2006;37:87–91.CrossRefGoogle ScholarPubMed
Henry, E, Walker, D, Wiedmeier, SE, Christensen, RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system. Am J Med Genet A 2007;143:42–50.CrossRefGoogle Scholar
Nijhawan, A, Baselga, E, Gonzalez-Ensenat, MA, et al. Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders. Arch Dermatol 2001;137:760–3.Google ScholarPubMed
Burch, JM, Weston, WL, Rogers, M, Morelli, JG. Cutaneous pustular leukemoid reactions in trisomy 21. Pediatr Dermatol 2003;20:232–7.CrossRefGoogle ScholarPubMed
Xu, G, Nagano, M, Kanezaki, R, Toki, T, Hayashi, Y, et al. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood 2003;102:2960–8.CrossRefGoogle ScholarPubMed
Crispino, JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 2005;16:137–47.CrossRefGoogle ScholarPubMed
Engmann, C, Donn, SM. Severe neutrophilia in an infant with persistent pulmonary hypertension of the newborn. Am J Perinatol 2003;20:347–51.Google Scholar
Alizadeh, P, Rahbarimanesh, AA, Bahram, MG, Salmasian, H. Leukocyte adhesion deficiency type 1 presenting as leukemoid reaction. Indian J Pediatr 2007;74:1121–3.CrossRefGoogle ScholarPubMed
Lambert, RM, Baer, VL, Wiedmeier, SE, Henry, E, Burnett, J, Christensen, RD. Isolated elevated blood neutrophil concentration at altitude does not require NICU admission if appropriate reference ranges are used. J Perinatol 2009;29:822–5.CrossRefGoogle ScholarPubMed
Wiedmeier, SE, Henry, E, Christensen, RD. Hematological abnormalities during the first week of life among neonates with trisomy 18 and trisomy 13: data from a multi-hospital healthcare system. Am J Med Genet A 2008;146:312–20.CrossRefGoogle Scholar
Brazy, JE, Grimm, JK, Little, VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr 1982;100:265.CrossRefGoogle ScholarPubMed
Koenig, JM, Christensen, RD. Indicence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Eng J Med 1989;321:557.CrossRefGoogle Scholar
Koenig, JM, Christensen, RD. The mechanism responsible for diminished neutrophil production in neonates delivered of women with pregnancy-induced hypertension. Am J Obstet Gynecol 1991;165:467.CrossRefGoogle ScholarPubMed
Doron, MW, Makhlouf, RA, Katz, VL, et al. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. J Pediatr 1994;125:452.CrossRefGoogle ScholarPubMed
Cadnapaphornchai, M, Faix, RG. Increased nosocomial infection in neutropenic low birth weight (2000 grams or less) infants of hypertensive mothers. J Pediatr 1992;121:956.CrossRefGoogle ScholarPubMed
Koenig, JM, Hunter, DD, Christensen, RD. Neutropenia in donor (anemic) twins involved in twin–twin transfusion syndrome. J Perinatol 1991;11:355.Google ScholarPubMed
Koenig, JM, Christensen, RD. Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Perinatol 1989;9:126.Google Scholar
Zook, KJ, Mackley, AB, Kern, J, Paul, DA. Hematologic effects of placental pathology on very low birthweight infants born to mothers with preeclampsia. J Perinatol 2009;29:8–12.CrossRefGoogle ScholarPubMed
Guner, S, Yigit, S, Cetin, M, et al. Evaluation of serum granulocyte colony stimulating factor levels in infants of preeclamptic mothers. Turk J Pediatr 2007;49:55–60.Google ScholarPubMed
Tsao, P-N, Teng, R-J, Tang, J-R, Yau K-I, T. Granulocyte colony-stimulating factor in the cord blood of premature neonates born to mothers with pregnancy-induced hypertension. J Pediatr 1999;135:56–9.CrossRefGoogle ScholarPubMed
Manzoni, P, Farina, D, Monetti, C, et al. Early-onset neutropenia is a risk factor for Candida colonization in very low-birth weight neoantes. Diagn Microbiol Infect Dis 2007;57:77–83.CrossRefGoogle Scholar
Teng, RJ, Wu, TJ, Garrison, RD, Sharma, R, Huday, ML. Early neutropenia is not associated with an increased rate of nosocomial infection in very low-birth-weight infants. J Perinatol 2009;29:219–24.CrossRefGoogle Scholar
Ahmad, M, Fleit, HB, Golightly, MG, LaGamma, EF. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates. Biol Neo 2004;86:48–54.CrossRefGoogle ScholarPubMed
Zuppa, AA, Girlando, P, Florio, MG, et al. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis. Eur J Obstet Gynecol Reprod Biol 2002;102:131–6.CrossRefGoogle ScholarPubMed
Kocherlakota, P, La Gamma, EF. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics 1998;102:1107–11.CrossRefGoogle ScholarPubMed
Bishop, CR, Rothstein, G, Ashenbrucker, HE, Athens, JW. Leukokinetic studies. XIV. Blood neutrophil kinetics in chronic, steady-state neutropenia. J Clin Invest 1971;50:1678–89.CrossRefGoogle ScholarPubMed
Joyce, RA, Boggs, DR. Visualizing the marrow granulocyte reserve. J Lab Clin Med 1979;93:101–10.Google ScholarPubMed
Christensen, RD, Rothstein, G. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 1980;96:316–18.CrossRefGoogle ScholarPubMed
Christensen, RD, Shigeoka, AO, Hill, HR, Rothstein, G. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis. Pediatr Res 1980;14:806–8.CrossRefGoogle ScholarPubMed
Calhoun, DA, Li, Y, Braylan, RC, Christensen, RD. Assessment of the contribution of the spleen to granulocytopoiesis and erythropoiesis of the mid-gestation human fetus. Early Hum Dev 1996;46:217–27.CrossRefGoogle ScholarPubMed
Boxer, LA. Severe congenital neutropenia: genetics and pathogenesis. Trans Am Clin Climatol Assoc 2006;137:13–32.Google Scholar
Boxer, LA. Immune neutropenias. Clinical and biological implications. Am J Pediatr Hematol Oncol 1981;3:89–96.Google ScholarPubMed
Party, IW. Nomenclature of granulocyte alloantigens. Vox Sang 1999;77:251.Google Scholar
Levine, DH, Madyastha, PR. Isoimmune neonatal neutropenia. Am J Perinatol 1986;3:231–3.CrossRefGoogle ScholarPubMed
Maheshwari, A, Christensen, RD, Calhoun, DA. Immune neutropenia in the neonate. Adv Pediatr 2002;49:317–39.Google ScholarPubMed
Kostmann, R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 1956;45:S1–78.CrossRefGoogle ScholarPubMed
Bonilla, MA, Gillio, AP, Ruggeiro, M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574–80.CrossRefGoogle ScholarPubMed
Dong, F, Brynes, RK, Tidow, N, Welte, K, Lowenberg, B, Touw, IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 1995;333:487–93.CrossRefGoogle ScholarPubMed
Zeidler, C, Schwinzer, B, Welte, K. Congenital neutropenias. Rev Clin Exp Hematol 2003;7:72–83.Google ScholarPubMed
Dale, DC, Bolyard, AA, Hammond, WP. Cyclic neutropenia: natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor. Cancer Invest 1993;11:219–23.CrossRefGoogle ScholarPubMed
Lange, RD. Cyclic hematopoiesis: human cyclic neutropenia. Exp Hematol 1983;11:435–51.Google ScholarPubMed
Boesen, P.Cyclic neutropenia terminating in permanent agranulocytosis. Acta Med Scand 1988;223:89–91.CrossRefGoogle ScholarPubMed
Jonsson, OG, Buchanan, GR. Chronic neutropenia during childhood. A 13-year experience in a single institution. Am J Dis Child 1991;145:232–5.CrossRefGoogle Scholar
Hammond, WP, Price, TH, Souza, LM, Dale, DC. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 1989;320:1306–11.CrossRefGoogle ScholarPubMed
Mack, DR, Forstner, GG, Wilschanski, M, Freedman, MH, Durie, PR. Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology 1996;111:1593–602.CrossRefGoogle ScholarPubMed
Shwachman, H, Diamond, LK, Oski, FA, Khaw, KT. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964;65:645–63.CrossRefGoogle ScholarPubMed
Smith, OP, Hann, IM, Chessells, JM, Reeves, BR, Milla, P. Haematological abnormalities in Shwachman–Diamond syndrome. Br J Haematol 1996;94:279–84.CrossRefGoogle ScholarPubMed
Burroughs, L, Woolfrey, A, Shimamura, A. Shwachman–Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am 2009;23:233–48.CrossRefGoogle Scholar
Kuijpers, TW, Alders, M, Tool, AT, Mellink, C, Roos, D, Hennekam, RC. Hematologic abnormalities in Shwachman–Diamond syndrome: lack of genotype–phenotype relationship. Blood 2005;106:356–61.CrossRefGoogle ScholarPubMed
Dror, Y, Freedman, MH. Shwachman–Diamond syndrome: an inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood 1999;94:3048–54.Google ScholarPubMed
Cesaro, S, Oneto, R, Messina, C, et al. Haematopoietic stem cell transplantation for Shwachman–Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol 2005;131:231–6.CrossRefGoogle ScholarPubMed
Donadieu, J, Michel, G, Merlin, E, et al. Hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transplant 2005;36:787–92.CrossRefGoogle ScholarPubMed
Visser, G, Rake, JP, Fernandes, J, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr 2000;137:187–91.CrossRefGoogle ScholarPubMed
Gitzelmann, R, Bosshard, NU. Defective neutrophil and monocyte functions in glycogen storage disease type Ib: a literature review. Eur J Pediatr 1993;152:S33–8.CrossRefGoogle ScholarPubMed
Lesma, E, Riva, E, Giovannini, M, Di Giulio, AM, Gorio, A. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b. Int J Immunopathol Pharmacol 2005;18:297–307.CrossRefGoogle ScholarPubMed
Pinsk, M, Burzynski, J, Yhap, M, Fraser, RB, Cummings, B, Ste-Marie, M. Acute myelogenous leukemia and glycogen storage disease 1b. J Pediatr Hematol Oncol 2002;24:756–8.CrossRefGoogle ScholarPubMed
Pierre, G, Chakupurakal, G, McKiernan, P, Hendriksz, C, Lawson, S, Chakrapani, A. Bone marrow transplantation in glycogen storage disease type 1b. J Pediatr 2008;152:286–8.CrossRefGoogle ScholarPubMed
Lux, SE, Johnston, RB, Jr., August, CS, et al. Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia. N Engl J Med 1970;282:231–6.CrossRefGoogle ScholarPubMed
Bertrand, Y, Muller, SM, Casanova, JL, Morgan, G, Fischer, A, Friedrich, W. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients. Bone Marrow Transpl 2002;29:759–62.CrossRefGoogle Scholar
Roper, M, Parmley, RT, Crist, WM, Kelly, DR, Cooper, MD. Severe congenital leukopenia (reticular dysgenesis). Immunologic and morphologic characterizations of leukocytes. Am J Dis Child 1985;139:832–5.CrossRefGoogle ScholarPubMed
De Santes, KB, Lai, SS, Cowan, MJ. Haploidentical bone marrow transplants for two patients with reticular dysgenesis. Bone Marrow Transp 1996;17:1171–3.Google ScholarPubMed
Charles, JM, Key, LL. Developmental spectrum of children with congenital osteopetrosis. J Pediatr 1998;132:371–4.CrossRefGoogle ScholarPubMed
el Khazen, N, Faverly, D, Vamos, E, et al. Lethal osteopetrosis with multiple fractures in utero. Am J Med Genet 1986;23:811–19.CrossRefGoogle ScholarPubMed
Golbus, MS, Koerper, MA, Hall, BD. Failure to diagnose osteopetrosis in utero. Lancet 1976;2:1246.CrossRefGoogle ScholarPubMed
Gerritsen, EJ, Vossen, JM, Fasth, A, et al. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group. J Pediatr 1994;125:896–902.CrossRefGoogle ScholarPubMed
Askmyr, MK, Fasth, A, Richter, J. Towards a better understanding and new therapeutics of osteopetrosis. Br J Haematol 2008;140:597–609.CrossRefGoogle ScholarPubMed
Villa, A, Guerrini, MM, Cassani, B, Pangrazio, A, Sobacchi, C. Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int 2009;84:1–12.CrossRefGoogle Scholar
Christensen, RD, Henry, E, Wiedmeier, SE, Stoddard, RA, Lambert, DK. Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 2006;26:682–7.CrossRefGoogle Scholar
Juul, SE, Haynes, JW, McPherson, RJ. Evaluation of neutropenia and neutrophilia in hospitalized preterm infants. J Perinatol 2004;24:150–7.CrossRefGoogle ScholarPubMed
Juul, SE, Calhoun, DA, Christensen, RD. “Idiopathic neutropenia” in very low birthweight infants. Acta Paediatr 1998;87:963–8.CrossRefGoogle ScholarPubMed
Juul, SE, Christensen, RD. Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with “idiopathic neonatal neutropenia”: a randomized, placebo-controlled trial. J Perinatol 2003;23:493–7.CrossRefGoogle ScholarPubMed
Cannistra, SA, Griffin, JD. Regulation of the production and action of granulocytes and monocytes. Semin Hematol 1988;25:173–88.Google Scholar
Golde, DW, Gasson, JC. Hormones that stimulate the growth of blood cells. Sci Am 1988;259:62–71.CrossRefGoogle ScholarPubMed
Davis, I, Morstyn, G. Clinical uses of growth factors. Baillieres Clin Haematol 1992;5:753–86.CrossRefGoogle ScholarPubMed
Sullivan, GW, Carper, HT, Mandell, GL. The effects of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin- 3) on phagocyte oxidative activity. Blood 1993;81:1963–70.Google ScholarPubMed
Dale, DC, Bonilla, MA, Davis, MW, et al. A randomized, controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993;81:2496.Google ScholarPubMed
Bonilla, MA, Gillio, AP, Ruggeiro, M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574–80.CrossRefGoogle ScholarPubMed
Corey, SJ, Wollman, MR, Deshpande, RV. Granulocyte colony-stimulating factor and congenital neutropenia – risk of leukemia?J Pediatr 1996;129:187–8.CrossRefGoogle ScholarPubMed
Dale, DC, Bolyard, AA, Hammond, WP. Cyclic neutropenia: natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor. Cancer Invest 1993;11:219–23.CrossRefGoogle ScholarPubMed
Cairo, M, Suen, Y, Knoppel, E, et al. Decreased GCSF and IL-3 production and gene expression from mononuclear cells of newborn infants. Pediatr Res 1992;31:574–8.CrossRefGoogle Scholar
Schibler, K, Leichty, K, White, W. Christensen, R. Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates. Blood 1993;82:2478–84.Google ScholarPubMed
Gessler, P, Kirchmann, N, Kientsch-Engel, R, et al. Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections. Blood 1993;82:3177–82.Google ScholarPubMed
Lieschke, G, Grail, D, Hodgson, G, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor deficiency, and impaired neutrophil mobilization. Blood 1994;84:1737–46.Google ScholarPubMed
Leichty, K, Schibler, K, Ohls, R, et al. The failure of newborn mice infected with Escherichia coli to accelerate neutrophil production correlates with their failure to increase transcripts for granulocyte colony-stimulating factor and interleukin-6. Biol Neonate 1993;64:331–40.CrossRefGoogle Scholar
Cairo, M, Plunkett, J, Mauss, D, van de Ven, C. Seven-day administration of recombinant granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B streptococcal sepsis. Blood 1990;76:1788–94.Google Scholar
Cairo, MS, van de Ven, C, Mauss, D, et al. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor. Biol Neonate 1991;59:13–21.CrossRefGoogle Scholar
Cairo, MS, Christensen, R, Sender, LS, et al. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood 1995;86:2509–15.Google ScholarPubMed
Lieschke, GJ, Stanley, E, Grail, D, et al. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 1994;84:27–35.Google ScholarPubMed
Kocherlakota, P, La Gamma, EF. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics 1997;100:E6.CrossRefGoogle ScholarPubMed
Carr, R, Modi, N, Dore, C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev 2003(3):CD003066.CrossRefGoogle ScholarPubMed
Ahmad, A, Laborada, G, Bussel, J, Nesin, M. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants. Pediatr Infect Dis J 2002;21:1061–5.CrossRefGoogle ScholarPubMed
Bedford Russell, AR, Emmerson, AJ, Wilkinson, N, et al. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed 2001;84:F172–6.CrossRefGoogle Scholar
Bilgin, K, Yaramis, A, Haspolat, K, Tas, MA, Gunbey, S, Derman, O. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 2001;107:36–41.Google ScholarPubMed
Drossou-Agakidou, V, Kanakoudi-Tsakalidou, F, Sarafidis, K, et al. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial. Eur J Pediatr 1998;157:583–8.CrossRefGoogle Scholar
Miura, E, Procianoy, RS, Bittar, C, et al. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2001;107:30–5.CrossRefGoogle ScholarPubMed
Schibler, KR, Osborne, KA, Leung, LY, Le, TV, Baker, SI, Thompson, DD. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 1998;102:6–13.CrossRefGoogle ScholarPubMed
Gillan, ER, Christensen, RD, Suen, Y, Ellis, R, van de Ven, C, Cairo, MS. A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood 1994;84:1427–33.Google ScholarPubMed
Bernstein, HM, Pollock, BH, Calhoun, DA, Christensen, RD. Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: A meta-analysis. J Pediatr 2001;138:917–20.CrossRefGoogle ScholarPubMed
La Gamma, E, Welch, W, Jeffs, R. A multicenter, double-blind, randomized, placebo-controlled safety and efficacy study of filgrastim (rHu-G-CSF) in the treatment of late-onset neonatal sepsis. Pediatr Res 2000;47:409A.Google Scholar
Calhoun, DA, Lunoe, M, Du, Y, Hutson, AD, Veerman, M, Christensen, RD. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor. Pediatrics 2000;105:392–7.CrossRefGoogle ScholarPubMed
Mouzinho, A, Rosenfeld, CR, Sanchez, P, et al. Effects of maternal hypertension on neonatal neutropenia and risk of nosocomial infection. Pediatrics 1992;90:430–5.Google Scholar
Doron, MW, Makhlouf, RA, Katz, VL, et al. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. Pediatr 1994;125:452–8.CrossRefGoogle ScholarPubMed
Cadnapaphornchai, M, Faix, RG. Increased nosocomial infection in neutropenic low birth weight (2000 grams or less) infants of hypertensive mothers. Pediatr 1992;121:956–61.CrossRefGoogle ScholarPubMed
La Gamma, EF, Alpan, O, Kocherlakota, P. Effects of granulocyte colony-stimulating factor on preeclampsia-associated neonatal neutropenia. J Pediatr 1995;126:457–9.CrossRefGoogle Scholar
Makhlouf, RA, Doron, MW, Bose, CL, et al. Administration of granulocyte colony-stimulating factor to neutropenic low birth weight infants of mothers with preeclampsia. J Pediatr 1995;126:454–6.CrossRefGoogle ScholarPubMed
Cairo, MS, Agosti, J, Ellis, R, et al. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr 1999;134:64–70.CrossRefGoogle ScholarPubMed
Carr, R, Modi, N, Dore, CJ, El-Rifai, R, Lindo, D. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation. Pediatrics 1999;103:796–802.CrossRefGoogle ScholarPubMed
Carr, R, Brocklehurst, P, Dore, CJ, Modi, N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet 2009;373:226–33.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×